These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 15686673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression.
    Lou HX, Vathsala A.
    Transplant Proc; 2004 Sep; 36(7):2090-1. PubMed ID: 15518756
    [Abstract] [Full Text] [Related]

  • 3. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
    Attallah N, Goggins M, Nori U, Abouljoud M, Zasuwa G, Venkat KK, Parasuraman R.
    Transplant Proc; 2005 Jun; 37(5):2060-2. PubMed ID: 15964338
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
    Ducloux D, Motte G, Billerey C, Bresson-Vautrin C, Vautrin P, Rebibou JM, Saint-Hillier Y, Chalopin JM.
    Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
    Gonzalez Molina M, Seron D, Garcia del Moral R, Carrera M, Sola E, Jesus Alferez M, Gomez Ullate P, Capdevila L, Gentil MA.
    Transplantation; 2004 Jan 27; 77(2):215-20. PubMed ID: 14742984
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.
    Meier-Kriesche HU, Steffen BJ, Hochberg AM, Gordon RD, Liebman MN, Morris JA, Kaplan B.
    Transplantation; 2003 Apr 27; 75(8):1341-6. PubMed ID: 12717227
    [Abstract] [Full Text] [Related]

  • 7. Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression.
    Lezaic VD, Marinkovic J, Ristic S, Dokic ZM, Basta Jovanovic G, Radivojevic DM, Blagojevic RN, Djukanovic LD.
    Transplant Proc; 2005 Mar 27; 37(2):734-6. PubMed ID: 15848517
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE, El-Dahshan K, Mahmoud K, Ismail AM, El-Baz M, Shokeir AA, Ghoneim MA.
    Exp Clin Transplant; 2008 Sep 27; 6(3):203-10. PubMed ID: 18954298
    [Abstract] [Full Text] [Related]

  • 12. Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy.
    David-Neto E, Araujo LM, Lemos FC, David DS, Mazzucchi E, Nahas WC, Arap S, Ianhez LE.
    Pediatr Transplant; 2001 Aug 27; 5(4):302-9. PubMed ID: 11472611
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
    Merion RM, Henry ML, Melzer JS, Sollinger HW, Sutherland DE, Taylor RJ.
    Transplantation; 2000 Jul 15; 70(1):105-11. PubMed ID: 10919583
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study.
    Dudley C, Pohanka E, Riad H, Dedochova J, Wijngaard P, Sutter C, Silva HT, Mycophenolate Mofetil Creeping Creatinine Study Group.
    Transplantation; 2005 Feb 27; 79(4):466-75. PubMed ID: 15729174
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D, Del Carmen Rial M, Vitko S, del Castillo D, Manas D, Lao M, Gafner N, Wijngaard P, Cyclosporine Withdrawal Study Group.
    J Am Soc Nephrol; 2005 Jul 27; 16(7):2234-40. PubMed ID: 15917338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.